Evidence map›Paper›PMID 31136562›Full record

ArticleJournal of pediatric gastroenterology and nutrition2019

Risk Factors for Rapid Progression From Acute Recurrent to Chronic Pancreatitis in Children: Report From INSPPIRE.

Quin Y Liu, Maisam Abu-El-Haija, Sohail Z Husain, Bradley Barth, Melena Bellin, Douglas S Fishman, Steven D Freedman, Cheryl E Gariepy, Matthew J Giefer, Tanja Gonska and 20 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in Journal of pediatric gastroenterology and nutrition, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
5.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it, 56 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Acute pancreatitis is associated with gut dysbiosis in children.Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver · 2024
    Observational
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Exocrine Pancreatic Insufficiency in Children - Challenges in Management.Pediatric health, medicine and therapeutics · 2023
    Review
  14. Article
  15. Hereditary pancreatitis: An updated review in pediatrics.World journal of clinical pediatrics · 2022
    Review
  16. Article
  17. Review
  18. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

30 authors at 15 institutions in 3 countries.

Quin Y LiuCedars-Sinai Medical Center, Los Angeles, CA.
Maisam Abu-El-HaijaDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH.
Sohail Z HusainDepartment of Pediatrics, Stanford University, Palo Alto, CA.
Bradley BarthUniversity of Texas Southwestern Medical School, Dallas, TX.
Melena BellinUniversity of Minnesota Masonic Children's Hospital, Minneapolis, MN.
Douglas S FishmanBaylor College of Medicine, Houston, TX.
Steven D FreedmanHarvard Medical School, Boston, MA.
Cheryl E GariepyNationwide Children's Hospital, Columbus, OH.
Matthew J GieferSeattle Children's Hospital, Seattle, WA.
Tanja GonskaHospital for Sick Children, Toronto, ON, Canada.
Melvin B HeymanUniversity of California San Francisco, San Francisco, CA.
Ryan HimesBaylor College of Medicine, Houston, TX.
Tom K LinDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH.
Asim MaqboolChildren's Hospital of Philadelphia, Philadelphia, PA.
Maria MascarenhasChildren's Hospital of Philadelphia, Philadelphia, PA.
Brian A McFerronRiley Hospital for Children, Indiana University School of Medicine, Indianapolis, IN.
Veronique D MorinvilleMontreal Children's Hospital, McGill University, Montreal, QC, Canada.
Jaimie D NathanDepartment of Pediatrics, College of Medicine, University of Cincinnati, Cincinnati, OH.
Chee Y OoiSchool of Women's and Children's Health, Medicine, University of New South Wales and Sydney Children's Hospital Randwick Sydney, Australia.
Emily R PeritoUniversity of California San Francisco, San Francisco, CA.
John F PohlUniversity of Utah, Salt Lake City, UT.
Sue RheeUniversity of California San Francisco, San Francisco, CA.
Sarah J SchwarzenbergBaylor College of Medicine, Houston, TX.
Uzma ShahMassachusetts General Hospital for Children, Harvard Medical School, Boston, MA.
David TroendleUniversity of Texas Southwestern Medical School, Dallas, TX.
Steven L WerlinMedical College of Wisconsin, Milwaukee, WI.
Michael WilschanskiHadassah Hebrew University Hospital, Jerusalem, Israel.
M Bridget ZimmermanDepartment of Biostatistics, University of Iowa, Iowa City, IA.
Mark E LoweWashington University School of Medicine, St Louis, MO.
Aliye UcUniversity of Iowa Stead Family Children's Hospital, Iowa City, IA.
The University of Texas Southwestern Medical Center · USUniversity of Cincinnati Medical Center · USBaylor College of Medicine · USStanford University · USCedars-Sinai Medical Center · USChildren's Hospital of Philadelphia · USHarvard University · USMontreal Children's Hospital · CANationwide Children's Hospital · USRiley Hospital for Children · USUniversity of California, San Francisco · USUniversity of Iowa · USUniversity of Minnesota Children's Hospital · USUNSW Sydney · AUWashington University in St. Louis · US

Funding

Vector Core-Core 2P30DK054759 · NIDDK · UNIVERSITY OF IOWA · PI Amy Leanne Ryan · 1998 to 2026
$30.5M
Year 9 Administrative Supplement to INSPPIRE 2U01DK108334 · NIDDK · UNIVERSITY OF IOWA · PI MARK E. LOWE, Aliye Uc · 2015 to 2026
$10.5M
University of Iowa Clinical and Translational Science ProgramUL1TR000442 · NCATS · UNIVERSITY OF IOWA · PI ROSENTHAL, GARY E · 2012 to 2013
$10.0M
DYSBIOTIC MICROBIOME IN PANCREATITIS, DIABETES, AND PANCREATIC CANCERU01DK108326 · NIDDK · BAYLOR COLLEGE OF MEDICINE · PI FISHER, WILLIAM E · 2015 to 2024
$5.2M
A Randomized Trial of a Web-based Non-Pharmacological Pain Intervention for Pediatric Chronic PancreatitisR01DK118752 · NIDDK · UNIVERSITY OF IOWA · PI PALERMO, TONYA M, UC, ALIYE · 2018 to 2022
$3.0M
INSPPIRE TO STUDY ACUTE RECURRENT AND CHRONIC PANCREATITIS IN CHILDRENR21DK096327 · NIDDK · UNIVERSITY OF IOWA · PI UC, ALIYE · 2012 to 2014
$586k
NCATS NIH HHS UL1 TR000442NIDDK NIH HHS P30 DK054759NIDDK NIH HHS R01 DK118752NIDDK NIH HHS R21 DK096327NIDDK NIH HHS U01 DK108326NIDDK NIH HHS U01 DK108334
6 · The paper itself

Abstract

objectiveThe aim of the study was to determine the rate of progression from acute recurrent pancreatitis (ARP) to chronic pancreatitis (CP) in children and assess risk factors. STUDY

designData were collected from the INternational Study group of Pediatric Pancreatitis: In search for a cuRE (INSPPIRE) cohort. Kaplan-Meier curves were constructed to calculate duration of progression from initial attack of acute pancreatitis (AP) to CP. Log-rank test was used to compare survival (nonprogression) probability distribution between groups. Cox proportional hazard regression models were fitted to obtain hazard ratio (with 95% confidence interval [CI]) of progression for each risk variable.

resultsOf 442 children, 251 had ARP and 191 had CP. The median time of progression from initial attack of AP to CP was 3.79 years. The progression was faster in those ages 6 years or older at the first episode of AP compared to those younger than 6 years (median time to CP: 2.91 vs 4.92 years; P = 0.01). Children with pathogenic PRSS1 variants progressed more rapidly to CP compared to children without PRSS1 variants (median time to CP: 2.52 vs 4.48 years; P = 0.003). Within 6 years after the initial AP attack, cumulative proportion with exocrine pancreatic insufficiency was 18.0% (95% CI: 12.4%, 25.6%); diabetes mellitus was 7.7% (95% CI: 4.2%, 14.1%).

conclusionsChildren with ARP rapidly progress to CP, exocrine pancreatic insufficiency, and diabetes. The progression to CP is faster in children who were 6 years or older at the first episode of AP or with pathogenic PRSS1 variants. The factors that affect the aggressive disease course in childhood warrant further investigation.

Indexed as

Age FactorsAustraliaCanadaChildChild, PreschoolCohort StudiesDisease ProgressionFemaleHumansIsraelMalePancreatitis, ChronicProportional Hazards ModelsRecurrenceRegression AnalysisRisk Factors

Identifiers

PMID31136562
PMCPMC6699635
OpenAlexW2947978745

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.